News

The company has named Dr. Rob Koremans as the president and CEO of Global Specialty Medicines. Koremans will report to Teva Pharmaceutical Industries president and CEO Dr. Jeremy

Galderma has worldwide marketing rights for Nuvo’s Pliaglis, a topical local anesthetic cream indicated for the production of local dermal anaesthesia preceding dermatological procedures in adults. Pliaglis leverages

The patent alleges a metered valve pump spray device comprising a liquid cannabis extract, in propylene glycol and ethanol, which is adapted to spray a dose towards a

Civil fraud lawsuit claimed that Novartis had disguised kickbacks as performance rebates and discounts to encourage pharmacies to oppose the use of cheaper, generic drugs or competitor drugs.

BioCarrier cases will provide regular route, multiple site sample collection and "home visit" temperature-sensitive injectable drug protection. Intelsius CEO David Walsh said that the company is introducing the

As per the agreement, AMRI may supply a range of services from drug discovery to cGMP manufacturing. The two companies have already agreed to collaborate on hit-to-lead and

Avalon will find the technology, provide management and ensures that the companies meet their milestones. GSK will offer its drug development and clinical testing expertise. According to the

Quarterly turnover was £6.47bn, down from restated £6.64bn for the same period last year. GSK delivered core EPS of 26.9pence and dividend of 18pence for the first quarter

The plan was announced along with the company’s first-quarter results that revealed the sales drop by 3% compared to previous year. According to GSK, the decision to pursue